Considering the heterogeneity of the two CRC cells on GPX4 expression, our research indicates an increase in lipid peroxidation with combined treatment, alongside a downregulation of the xCT expression compared to MET treatment alone when combined with CUR. Here, GPX4 is linked to colorectal carcinoma.